Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $558.9K | $269.0K |
| Operating income | −$1.5M | −$4.5M | −$2.5M | −$2.4M | −$5.5M | −$5.0M | −$3.1M | −$2.9M |
| EBITDA | −$1.2M | −$3.8M | −$2.5M | −$2.4M | −$5.5M | −$5.0M | −$4.3M | −$3.6M |
| Net income | −$1.9M | −$5.3M | −$4.6M | −$1.5M | −$5.5M | −$5.8M | −$6.5M | −$5.3M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -0.90 | -1.60 | -0.70 | -0.20 | -0.50 | -0.49 | -0.49 | -0.31 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds IRBS.
No tracked institution reports a position in IRBS as of their last filing.
| Execution date | Ratio |
|---|---|
| 2004-04-06 | 2-for-1 |
| 2003-07-02 | 1-for-20reverse |
No one on the platform has traded IRBS yet.
| $162828 |
| — |
| GSTCGlobeStar Therapeutics Corporation | $0.00 | +0.00% | $124111 | — |
| HTDSHard to Treat Diseases Inc. | $0.00 | +0.00% | $109647 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.